[1]
Bonadio, R.R. da C.C. et al. 2026. Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triplenegative breast cancer in a real-world scenario: the Neo-Real/GBECAM-0123 study. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1002.